GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » Tax Expense

Kangji Medical Holdings (HKSE:09997) Tax Expense : HK$159 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings Tax Expense?

Kangji Medical Holdings's tax expense for the months ended in Jun. 2024 was HK$56 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2024 was HK$159 Mil.


Kangji Medical Holdings Tax Expense Historical Data

The historical data trend for Kangji Medical Holdings's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangji Medical Holdings Tax Expense Chart

Kangji Medical Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial 71.73 60.37 95.15 113.87 149.28

Kangji Medical Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.41 67.75 45.92 103.35 56.03

Kangji Medical Holdings Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$159 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kangji Medical Holdings  (HKSE:09997) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Kangji Medical Holdings Tax Expense Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangji Medical Holdings Business Description

Traded in Other Exchanges
Address
No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN
Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The principal activities of the Company are to design, develop, manufacture and sell a comprehensive suite of MISIA that are focused on the surgical specialties of OBGYN, urology, general surgery and thoracic surgery. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, It derives the majority of its revenue from Mainland China.
Executives
Butterfield Trust (asia) Limited 2301 Trustee
Fortune Spring Zm Aa Limited 2101 Beneficial owner
Yg Aa Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2201 Interest of corporation controlled by you
Zhong Ming 2501 Other
Fortune Spring Yg B Limited 2101 Beneficial owner
Shentu Yinguang 2501 Other
Fortune Spring Zm B Limited 2101 Beneficial owner
Credit Suisse Trust Limited 2201 Interest of corporation controlled by you
Bonderman David 2201 Interest of corporation controlled by you
Coulter James George 2201 Interest of corporation controlled by you
Keyhole Holding Limited 2101 Beneficial owner
Tpg Asia Genpar Vii Advisors, Inc. 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Group Holdings (sbs) Advisors, Inc. 2201 Interest of corporation controlled by you

Kangji Medical Holdings Headlines

No Headlines